Ignite Creation Date:
2024-05-06 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03636620
Status:
COMPLETED
Last Update Posted:
2018-08-17
First Post:
2018-08-08
Brief Title:
TACE Combined With RFAMV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial
Sponsor:
Fudan University
Organization:
Fudan University
Study Overview
Official Title:
Clinical Trial of Transcatheter Arterial Chemoembolization Combined With RadiofrequencyMicrowave Ablation in Hepatocellular Carcinoma Beyond Milan Criterial
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TACERFA
Brief Summary:
This study was designed to evaluate the effectiveness of radiofrequency microwave ablation in patients with hepatocellular carcinoma beyond Milan Criteria
Detailed Description:
The aim of this study is to included 120 patients with intermediate stage hepatocellular carcinoma beyond Milan criteria These patients were randomizedly allocated to TACE treatment group or TACERFAMV The treatment effectiveness local tumor control and survival outcome between the two groups were compared
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None